69P The burden of financial toxicity (FT) in adult rare cancers: Evidence from a systematic review across EURACAN domains

ESMO rare cancers. 2026 Open access

Read full text
Authors: Luigi Cerbone, Roberto Buonaiuto, Alessia Garau, Carlotta Bertolina, Riccardo Mazzucco, Roberto Simioli, P. Gargiulo, Maria Carmela Piccirillo, F. Grosso, Martina Pagliuca
DOI: 10.1016/j.esmorc.2026.100275
Cited by: 0

Abstract

FT is an emerging, patient-reported side effect of cancer care, linked to poorer quality of life (QoL), psychological distress and worse outcomes. Adults with rare cancers (ARC) face long diagnostic pathways, complex therapies, and care delivery in referral centers, potentially increasing FT. Our aim was to assess the impact of FT in ARC on QoL and survival outcomes.

Fields of Study & Subjects

Economic and Financial Impacts of Cancer Cancer survivorship and care Health Systems Economic Evaluations Quality of Life

Publication details

Journal / source
ESMO rare cancers.
Volume
5
Pages
100275–100275
Publication date
1 March 2026
Language
EN